Saturday 17 October 2026 Export NKTR’s income statement to Excel — free account

Nektar Therapeutics

Nektar Therapeutics' revenue for fiscal 2025 (year ended December 2025) was $55.2 million, down 43.9% from fiscal 2024. In the quarter to June 2026, revenue fell 9.34%, EPS grew 58.3% and free cash flow fell 65.7%, each against the same quarter a year earlier.

35.78 1.94 −5.14%

Follow NKTR

Alert me

Market cap: $1.3B
P/E: 0.0×
Fwd P/E: −6.3×
Dividend yield: —
F-score: 3/9
Altman Z: −17.07
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	42.27	31.99	12.91	17.22
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(30.45)	(40.18)	(10.98)	(22.11)
P/B ratio Full definition →	2.56	3.09	7.94	12.67
Price to Tangible BV Full definition →	2.57	3.12	8.42	13.49
EV/Sales Full definition →	38.94	30.80	17.56	20.93
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(9.09)	(8.41)	(4.65)	(6.91)
EV/FCF Full definition →	(9.08)	(8.40)	(4.65)	(6.88)
Quick Ratio Full definition →	9.64	9.85	4.59	4.07
Current Ratio Full definition →	10.42	10.21	4.97	4.24
Net Debt/EBITDA Full definition →	14.96	14.02	10.30	8.21
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.08	0.11	0.19	0.21
Operating CF/Net income Full definition →	1.87	0.99	1.80	1.37
Capex/Depreciation Full definition →	0.03	0.01	0.00	0.09
Interest Coverage Full definition →	(5.88)	(4.92)	(2.83)	(5.24)
Research and Development Expense of Revenue Full definition →	386.23%	328.51%	136.25%	231.15%
Selling, General and Administrative Expense of Revenue Full definition →	126.00%	123.74%	51.29%	136.30%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.02
Share Based Compensation of Revenue Full definition →	33.21%	30.89%	10.06%	26.06%
Graham Net Nets Full definition →	0.24	0.23	0.11	0.06
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(9.60%)	(11.70%)	(24.12%)	(14.00%)
Free Cash Flow Yield Full definition →	(10.14%)	(11.46%)	(29.26%)	(17.66%)
Revenue per Share Full definition →	0.31	0.44	1.29	0.62
Operating CF per Share Full definition →	(2.29)	(1.79)	(3.85)	(2.57)
Capex per Share Full definition →	0.00	0.00	0.00	(0.01)
Free Cash Flow per Share Full definition →	(2.30)	(1.79)	(3.85)	(2.58)
Cash per Share Full definition →	20.70	22.99	14.57	14.26
Shareholders Equity per Share Full definition →	27.32	23.29	5.32	4.49
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	27.32	23.29	5.32	4.49
Free Cash Flow Full definition →	(75.86)	(44.32)	(64.98)	(48.87)
Working Capital Full definition →	668.42	531.33	212.73	215.02
Capital Expenditures Full definition →	(0.09)	(0.02)	(0.02)	(0.11)
Net Current Asset Value Full definition →	547.39	401.99	75.69	65.10
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.01	0.00	0.00	0.01
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →	19.59	13.93	11.17	12.07
Average Assets Full definition →	651.33	509.76	292.13	304.66
Average Common Equity Full definition →	439.46	294.98	75.28	66.99

Fold the line items

Columns are period end dates

Stockrow Weekly